MYCN and neuroblastoma: Therefore, the variables age ≥ 18 months, LDH ≥ 1400 U/L, and the genomic pattern (GG-P2s and BPs ≥ 7) will be good candidates for predicting the outcomes of patients with stage 4, MYCN non-amplified NB tumors.